Network variation - Complement cascade
|
| ENTRY | nt06513 |
| Name | Complement cascade |
| Category | Pathway view; Immune system |
| Pathway | hsa04610 Complement and coagulation cascades |
| Disease | H00102 Classic complement pathway component defects H00105 Mannose-binding lectin pathway component defects H00104 Alternative complement pathway component defects H00103 Late complement pathway defects H00106 Complement regulatory protein defects |
| Display | drug-target relation disease type |
| Disease name | Disease category | ||
| C4a deficiency | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| C4b deficiency | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| C2 deficiency/ARMD14 | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| C1qa deficiency | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| C1qb deficiency | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| C1qc deficiency | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| EDSPD1 | H02240 | Ehlers-Danlos syndrome periodontal type | Congenital malformation |
| C1s deficiency/EDSPD2 | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| H02240 | Ehlers-Danlos syndrome periodontal type | Congenital malformation | |
| SARS-CoV-2 | H02398 | COVID-19 | Viral infectious disease |
| KSHV | H00041 | Kaposi sarcoma | Cancer |
| LCAPD1 | H00105 | Mannose-binding lectin pathway component defects | Primary immunodeficiency |
| LCAPD2 | H00105 | Mannose-binding lectin pathway component defects | Primary immunodeficiency |
| LCAPD3 | H00105 | Mannose-binding lectin pathway component defects | Primary immunodeficiency |
| 3MC1 | H01887 | 3MC syndrome | Congenital malformation |
| 3MC2 | H01887 | 3MC syndrome | Congenital malformation |
| 3MC3 | H01887 | 3MC syndrome | Congenital malformation |
| C3 deficiency/ARMD9/AHUS5 | H00102 | Classic complement pathway component defects | Primary immunodeficiency |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| H01434 | Atypical hemolytic uremic syndrome | Hematologic disease | |
| HSV | H00365 | Herpes simplex virus infection | Viral infectious disease |
| CFB deficiency/ARMD14/AHUS4 | H00104 | Alternative complement pathway component defects | Primary immunodeficiency |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| H01434 | Atypical hemolytic uremic syndrome | Hematologic disease | |
| CFP deficiency | H00104 | Alternative complement pathway component defects | Primary immunodeficiency |
| C5D | H00103 | Late complement pathway defects | Primary immunodeficiency |
| C6D | H00103 | Late complement pathway defects | Primary immunodeficiency |
| C7D | H00103 | Late complement pathway defects | Primary immunodeficiency |
| C8D1 | H00103 | Late complement pathway defects | Primary immunodeficiency |
| C8D2 | H00103 | Late complement pathway defects | Primary immunodeficiency |
| C9D/ARMD15 | H00103 | Late complement pathway defects | Primary immunodeficiency |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| CD59 deficiency | H00106 | Complement regulatory protein defects | Primary immunodeficiency |
| CFH deficiency/C3G1/BLD/ARMD4/AHUS1 | H00104 | Alternative complement pathway component defects | Primary immunodeficiency |
| H02579 | C3 glomerulopathy | Immune system disease | |
| H02108 | Basal laminar drusen | Nervous system disease | |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| H01434 | Atypical hemolytic uremic syndrome | Hematologic disease | |
| CD55 deficiency | H00106 | Complement regulatory protein defects | Primary immunodeficiency |
| CFI deficiency/C3G2/ARMD13/AHUS3 | H00106 | Complement regulatory protein defects | Primary immunodeficiency |
| H02579 | C3 glomerulopathy | Immune system disease | |
| H00821 | Age-related macular degeneration | Nervous system disease | |
| H01434 | Atypical hemolytic uremic syndrome | Hematologic disease | |
| AHUS2 | H01434 | Atypical hemolytic uremic syndrome | Hematologic disease |
| ARMD1/AHUS1 | H00821 | Age-related macular degeneration | Nervous system disease |
| H01434 | Atypical hemolytic uremic syndrome | Hematologic disease | |
| C3G3 | H02579 | C3 glomerulopathy | Immune system disease |
| C1NH deficiency | H00106 | Complement regulatory protein defects | Primary immunodeficiency |
| Drug name | ||
| D1 | D12252 | Iptacopan hydrochloride (USAN) |
| D2 | D03940 | Eculizumab (USAN/INN) |
| D3 | D11054 | Ravulizumab (USAN/INN) |
| D4 | D11696 | Crovalimab (USAN/INN) |
| D5 | D01136 | Tranexamic acid (JP18/USP/INN) |
| D6 | D13074 | Ebribafusp alfa (USAN/INN) |